Picture of AFT Pharmaceuticals logo

AFP AFT Pharmaceuticals Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Annual cashflow statement for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.

C2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash from Operating Activities-9.171.0714.90.7514.2
Capital Expenditures-2.85-3.46-6.56-6.23-5.58
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-3-1.420
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-5.86-4.88-6.56-6.23-5.58
Financing Cash Flow Items-1.93-3.56-5.9-4.19-2.19
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.863.72-9.122.52-3.91
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-9.130.146-0.797-2.914.73

Or unlock with your email

Or unlock with your email